Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Med Mycol. 2024 Jan 27;62(2). doi: 10.1093/mmy/myae002.
Infections with Scedosporium spp. are emerging in the past two decades and are associated with a high mortality rate. Microbiological detection can be associated with either colonization or infection. Evolution from colonization into infection is difficult to predict and clinical management upon microbiological detection is complex. Microbiological samples from 2015 to 2021 were retrospectively analyzed in a single tertiary care center. Classification into colonization or infection was performed upon first microbiological detection. Clinical evolution was observed until July 2023. Further diagnostic procedures after initial detection were analyzed. Among 38 patients with microbiological detection of Scedosporium spp., 10 were diagnosed with an infection at the initial detection and two progressed from colonization to infection during the observation time. The main sites of infection were lung (5/12; 41.6%) followed by ocular sites (4/12; 33.3%). Imaging, bronchoscopy or biopsies upon detection were performed in a minority of patients. Overall mortality rate was similar in both groups initially classified as colonization or infection [30.7% and 33.3%, respectively (P = 1.0)]. In all patients where surgical debridement of site of infection was performed (5/12; 42%); no death was observed. Although death occurred more often in the group without eradication (3/4; 75%) compared with the group with successful eradication (1/8; 12.5%), statistical significance could not be reached (P = 0.053). As therapeutic management directly impacts patients' outcome, a multidisciplinary approach upon microbiological detection of Scedosporium spp. should be encouraged. Data from larger cohorts are warranted in order to analyze contributing factors favoring the evolution from colonization into infection.
在过去的二十年中,鞘孢菌属感染不断出现,并与高死亡率相关。微生物学检测既可以与定植相关,也可以与感染相关。从定植向感染的转变难以预测,且在微生物学检测后临床管理较为复杂。在一家三级保健中心,对 2015 年至 2021 年的微生物学样本进行了回顾性分析。在首次微生物学检测时进行定植或感染的分类。观察到临床演变直至 2023 年 7 月。分析了初始检测后进一步的诊断程序。在 38 例微生物学检测到鞘孢菌属的患者中,10 例在初始检测时被诊断为感染,2 例在观察期间从定植发展为感染。感染的主要部位是肺部(5/12;41.6%),其次是眼部(4/12;33.3%)。少数患者进行了影像学、支气管镜检查或活检。最初分类为定植或感染的两组患者的总体死亡率相似[分别为 30.7%和 33.3%(P=1.0)]。在所有进行感染部位清创术的患者(5/12;42%)中,未观察到死亡。尽管未消除感染组(3/4;75%)的死亡例数多于成功消除感染组(1/8;12.5%),但无统计学意义(P=0.053)。由于治疗管理直接影响患者的预后,因此应鼓励在鞘孢菌属微生物学检测时采用多学科方法。为了分析有利于从定植向感染转变的因素,需要更大的队列数据。